330 related articles for article (PubMed ID: 31462215)
1. Risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia and clinical impact of quinolone-resistant strains.
Kim EJ; Kim YC; Ahn JY; Jeong SJ; Ku NS; Choi JY; Yeom JS; Song YG
BMC Infect Dis; 2019 Aug; 19(1):754. PubMed ID: 31462215
[TBL] [Abstract][Full Text] [Related]
2. Clinical predictors of Stenotrophomonas maltophilia bacteremia in adult patients with hematologic malignancy.
Kim SH; Cho SY; Kang CI; Seok H; Huh K; Ha YE; Chung DR; Lee NY; Peck KR; Song JH
Ann Hematol; 2018 Feb; 97(2):343-350. PubMed ID: 29138886
[TBL] [Abstract][Full Text] [Related]
3. Comparisons between patients with trimethoprim-sulfamethoxazole-susceptible and trimethoprim-sulfamethoxazole-resistant Stenotrophomonas maltophilia monomicrobial bacteremia: A 10-year retrospective study.
Wang CH; Lin JC; Lin HA; Chang FY; Wang NC; Chiu SK; Lin TY; Yang YS; Kan LP; Yang CH; Chan MC; Yeh KM
J Microbiol Immunol Infect; 2016 Jun; 49(3):378-86. PubMed ID: 25081988
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia.
Lai CH; Chi CY; Chen HP; Chen TL; Lai CJ; Fung CP; Yu KW; Wong WW; Liu CY
J Microbiol Immunol Infect; 2004 Dec; 37(6):350-8. PubMed ID: 15599467
[TBL] [Abstract][Full Text] [Related]
5. Clinical Characteristics of Rapidly Progressive Fatal Hemorrhagic Pneumonia Caused by Stenotrophomonas maltophilia.
Imoto W; Yamada K; Yamairi K; Shibata W; Namikawa H; Yukawa S; Yoshii N; Nakaie K; Hirose A; Koh H; Watanabe T; Asai K; Nakamae H; Kaneko Y; Kawaguchi T; Hino M; Kakeya H
Intern Med; 2020; 59(2):193-198. PubMed ID: 31941869
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia.
Jeon YD; Jeong WY; Kim MH; Jung IY; Ahn MY; Ann HW; Ahn JY; Han SH; Choi JY; Song YG; Kim JM; Ku NS
Medicine (Baltimore); 2016 Aug; 95(31):e4375. PubMed ID: 27495046
[TBL] [Abstract][Full Text] [Related]
7. The clinical impact of Stenotrophomonas maltophilia bacteremia on the 30-day mortality rate in patients with hematologic disorders: a single-institution experience.
Bao H; Qiao Y; Liu D; Chen J; Wu X; Hu X; Ma X; Wu D
Infection; 2020 Apr; 48(2):205-212. PubMed ID: 31686323
[TBL] [Abstract][Full Text] [Related]
8. Comparison of clinical characteristics of bacteremia from Elizabethkingia meningoseptica and other carbapenem-resistant, non-fermenting Gram-negative bacilli at a tertiary medical center.
Huang YC; Wu PF; Lin YT; Wang FD
J Microbiol Immunol Infect; 2019 Apr; 52(2):304-311. PubMed ID: 30097388
[TBL] [Abstract][Full Text] [Related]
9. Stenotrophomonas maltophilia bacteremia in adults: four years' experience in a medical center in northern Taiwan.
Wang WS; Liu CP; Lee CM; Huang FY
J Microbiol Immunol Infect; 2004 Dec; 37(6):359-65. PubMed ID: 15599468
[TBL] [Abstract][Full Text] [Related]
10. Treatment Outcomes of Stenotrophomonas maltophilia Bacteremia in Critically Ill Children: A Multicenter Experience.
Tokatly Latzer I; Nahum E; Cavari Y; Lazar I; Ben-Ari Y; Ben-Shimol S; Ben-Shalom G; Geffen Y; Goldberg L; Rubinstein M; Keller N; Pessach IM; Paret G
Pediatr Crit Care Med; 2019 May; 20(5):e231-e239. PubMed ID: 31058792
[TBL] [Abstract][Full Text] [Related]
11. Pathogenic significance of hemorrhagic pneumonia in hematologic malignancy patients with Stenotrophomonas maltophilia bacteremia: clinical and microbiological analysis.
Kim SH; Cha MK; Kang CI; Ko JH; Huh K; Cho SY; Chung DR; Peck KR
Eur J Clin Microbiol Infect Dis; 2019 Feb; 38(2):285-295. PubMed ID: 30421302
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for mortality in
Huang C; Lin L; Kuo S
Infect Dis (Lond); 2024 May; 56(5):335-347. PubMed ID: 38436567
[TBL] [Abstract][Full Text] [Related]
13. Stenotrophomonas maltophilia bloodstream infection in patients with hematologic malignancies: a retrospective study and in vitro activities of antimicrobial combinations.
Cho SY; Lee DG; Choi SM; Park C; Chun HS; Park YJ; Choi JK; Lee HJ; Park SH; Choi JH; Yoo JH
BMC Infect Dis; 2015 Feb; 15():69. PubMed ID: 25887489
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for death from Stenotrophomonas maltophilia bacteremia.
Osawa K; Shigemura K; Kitagawa K; Tokimatsu I; Fujisawa M
J Infect Chemother; 2018 Aug; 24(8):632-636. PubMed ID: 29673561
[TBL] [Abstract][Full Text] [Related]
15. Bacteraemia due to Stenotrophomonas maltophilia: an analysis of 45 episodes.
Friedman ND; Korman TM; Fairley CK; Franklin JC; Spelman DW
J Infect; 2002 Jul; 45(1):47-53. PubMed ID: 12217732
[TBL] [Abstract][Full Text] [Related]
16. Stenotrophomonas maltophilia bacteremia and pneumonia at a tertiary-care oncology center: a review of 16 years.
Velázquez-Acosta C; Zarco-Márquez S; Jiménez-Andrade MC; Volkow-Fernández P; Cornejo-Juárez P
Support Care Cancer; 2018 Jun; 26(6):1953-1960. PubMed ID: 29307014
[TBL] [Abstract][Full Text] [Related]
17. [Risk factors and clinical charasteristics of Stenotrophomonas maltophilia bacteremia: a comparison with bacteremia due to other glucose-non fermenters].
Hotta G; Matsumura Y; Kato K; Nakano S; Yunoki T; Yamamoto M; Nagao M; Ito Y; Takakura S; Ichiyama S
Kansenshogaku Zasshi; 2013 Sep; 87(5):596-602. PubMed ID: 24195169
[TBL] [Abstract][Full Text] [Related]
18. Clinical Features and Risk Factors for Development of Breakthrough Gram-Negative Bacteremia during Carbapenem Therapy.
Lee JY; Kang CI; Ko JH; Lee WJ; Seok HR; Park GE; Cho SY; Ha YE; Chung DR; Lee NY; Peck KR; Song JH
Antimicrob Agents Chemother; 2016 Nov; 60(11):6673-6678. PubMed ID: 27572416
[TBL] [Abstract][Full Text] [Related]
19. Stenotrophomonas maltophilia bacteremia in children: risk factors and mortality rate.
Alsuhaibani M; Aljarbou A; Althawadi S; Alsweed A; Al-Hajjar S
Antimicrob Resist Infect Control; 2021 Jan; 10(1):19. PubMed ID: 33482916
[TBL] [Abstract][Full Text] [Related]
20. Fatal hemorrhagic pneumonia in patients with hematologic diseases and Stenotrophomonas maltophilia bacteremia: a retrospective study.
Zhu L; Wang L; Zhang Y; Chen R; Li X; Sun J; Zhou D; Zhu M; Zheng X; Li L; Zhu J; Xie M; Yang X; Yu W; Tong H; Zhu H; Xie W; Jin J; Ye X
BMC Infect Dis; 2021 Jul; 21(1):723. PubMed ID: 34332526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
